Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00486707 · ClinicalTrials.gov registry record
Ovarian Cancer Patient Questionnaire on Genetic Testing
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 237
- Enrollment target
NCT00486707: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00486707 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 237 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00486707 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 237 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the willingness of patients with ovarian cancer to undergo genetic testing, given the cost, their understanding and acceptance of genetic testing and the possibility of targeted therapy.
Interventions
- BEHAVIORAL Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 237 participants |
| Start Date | 2007-06 |
| Est. Completion | 2008-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00486707
The ClinicalTrials.gov registry entry for NCT00486707 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 237 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire is the first listed.
NCT00486707 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00486707 about?
NCT00486707 is a clinical study titled "Ovarian Cancer Patient Questionnaire on Genetic Testing". The objective of this study is to evaluate the willingness of patients with ovarian cancer to undergo genetic testing, given the cost, their understanding and acceptance of genetic testing and the possibility of targeted therapy.
What is the current status of trial NCT00486707?
This trial is currently completed. The enrollment target is 237 participants. The study started on 2007-06. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00486707?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00486707?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.